Given that in clinical practice, although both occurred in the liver, we have clearly found that HCC has an out better blood supply than ICC, it is speculated that FOLR2+ TAM lacks this oxygen competition phenomenon with HCC tumor cells, without the phenotype transformation to SPP1+ macrophages. The gene discussed is FOLR2; the disease is hepatocellular carcinoma.